33 results on '"Zabalza, Amaya"'
Search Results
2. The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
3. Concomitant lymphoplasmacytic lymphoma, multiple myeloma, and amyloidosis: A diagnostic and therapeutic challenge
4. IRON OVERLOAD IN A BREAST CANCER PATIENT WITH A HOMOZYGOUS MUTATION IN THE HFE HEMOSTATIC IRON REGULATOR GENE: CONSIDERATIONS REGARDING THE USE OF ADJUVANT HORMONE THERAPY
5. Mobilization of hematopoietic progenitor cells from allogeneic healthy donors using a new biosimilar G-CSF (Zarzio®)
6. Additional file 1 of Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
7. Worldwide Examination of Patients with CLL Hospitalized for COVID-19
8. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
9. Utilidad clínica del biomarcador bismetilgliotoxina para el manejo de pacientes en riesgo de infección viral después del trasplante de progenitores hematopoyético alogénico
10. Predicción del riesgo de infección por citomegalovirus después del trasplante de progenitores hematopoyeticos alogénico a través del análisis de la funcionalidad linfocitaria especifica del virus
11. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
12. MULTILINEAGE ACUTE LEUKEMIA DURING THE TREATMENT OF A PATIENT WITH BREAST CANCER WITH DOCETAXEL AND DOUBLE ANTI-HER2/NEU BLOCKADE: PERSPECTIVES AND POINTS TO CONSIDER
13. Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma
14. Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients
15. Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience
16. Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8+T cells by flow cytometry
17. Monitoring early CMV-specific CD8+ T-cell responses after allogeneic stem cell transplantation by HLA-multimers
18. Pentamers and streptamers for the monitoring of CMV-specific CD8+ T-cell immune-reconstitution after allogeneic stem cell transplantation: a comparative analysis
19. Reproducibility of Pentamer and Streptamer staining of CMV-specific CD8+ T-cells: defining the optimal multimer concentration and incubation conditions
20. Busulfan‐based myeloablative conditioning regimens for haploidentical transplantation in high‐risk acute leukemias and myelodysplastic syndromes.
21. Mobilization of hematopoietic progenitor cells from allogeneic healthy donors using a new biosimilar G-CSF (Zarzio®)
22. Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood
23. Alemtuzumab As Pre-Conditioning Is Safe and Feasible in Patients with T-Cell Lymphoid Neoplasms Undergoing Allogeneic Stem Cell Transplantation
24. High Mortality Associated with Neurological Complications after Allogeneic Stem Cell Transplantation
25. CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers
26. Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8+ T cells by flow cytometry.
27. Monitoring Early CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation By Pentamer and Streptamer Staining
28. Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review
29. Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy
30. Tiempos modernos: retorno al pasado, regreso al futuro
31. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.
32. Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8 + T cells by flow cytometry.
33. [Modern times: back to past, back to future].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.